Exane Derivatives’s State Street STT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-276
Closed -$24K 907
2022
Q1
$24K Buy
+276
New +$25.6K 0.01% 646
2021
Q4
Sell
-880
Closed -$74.6K 959
2021
Q3
$74.6K Sell
880
-139
-14% -$12.1K 0.02% 576
2021
Q2
$85.2K Buy
1,019
+68
+7% +$5.74K 0.02% 564
2021
Q1
$79.9K Buy
+951
New +$73.7K 0.02% 454
2019
Q4
Sell
-25
Closed -$1.48K 707
2019
Q3
$1.48K Sell
25
-4,500
-99% -$250K ﹤0.01% 514
2019
Q2
$254K Buy
4,525
+1,641
+57% +$102K 0.04% 237
2019
Q1
$190K Buy
2,884
+1,084
+60% +$75.1K 0.04% 222
2018
Q4
$113K Buy
+1,800
New +$129K 0.02% 308

Other funds holding STT

Exane Derivatives's STT Position: Q2 2022 in Review

Exane Derivatives sold out of State Street (STT) in Q2 2022, closing a stake of 276 shares — an estimated $24K sold.

Exane Derivatives first reported a position in STT in Q4 2018 and held it in 8 quarters. The position peaked at $254K in Q2 2019. 839 funds tracked by Wall St. Rank hold STT as of Q2 2022.

  • Exane Derivatives reported no remaining State Street position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 276 State Street shares in Q2 2022, an estimated $24K.
  • Exane Derivatives first reported a position in State Street in Q4 2018 and held it in 8 quarters.
  • Exane Derivatives's State Street position peaked at $254K in Q2 2019.
  • 839 funds tracked by Wall St. Rank held State Street as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.